<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
</head>
<body><p style="text-align:justify;"><span >Leukaemia is cancer of the blood cells.  There are two main types  of leukaemia, which are lymphoid leukaemia and myeloid leukaemia. Each type of leukaemia can be classified as acute (where the patient falls suddenly ill) and chronic (where the patient may have been harbouring the disease for months without knowing). Thus in all, there are 4 main types of leukaemia: acute lymphoid leukaemia (ALL), chronic lymphoid leukaemia (CLL), acute myeloid leukaemia (AML) and chronic myeloid leukaemia (CML).</span></p><p style="text-align:justify;"><span >ALL is commonest in children especially boys, CLL is commonest in the elderly, AML and CML cut across all age groups and sexes.</span></p><p style="text-align:justify;"><span >The abnormal leukaemic cells especially in acute leukaemia, fill the marrow and prevent the marrow from producing the normal blood cells</span></p><p style="text-align:justify;"><span >i.e. red cells, white cells and platelets leading to anaemia, neutropaenia and thrombocytopaenia, respectively.</span></p><h3>CAUSES</h3><ul><li>Usually unknown</li><li>Associated factors<ul><li>Viruses e.g. human T lymphotrophic virus type 1 (HTLV-1) and epstein barr virus (EBV)</li><li>Chemicals e.g. benzene, industrial solvents, pesticides(lindane), dyes,</li><li>Drugs e.g. alkylating agents such as melphalan</li><li>Ionizing radiation</li></ul></li></ul><h3>SYMPTOMS</h3><p><strong>Acute Leukaemia</strong></p><ul><li>Fever</li><li>Lymph node swelling</li><li>Easy fatiguability</li><li>Bruising tendencies</li><li>Bone and joint pain (especially in children)</li></ul><h3>Chronic Leukaemia</h3><ul><li>Asymptomatic</li><li>Dragging sensation (left side of abdomen)</li><li>Easy satiety</li><li>Lymph node swelling</li><li>Weight loss</li><li>Generalized itch</li><li>Excessive sweating</li><li>Priapism</li><li>Hearing loss</li></ul><h3>SIGNS</h3><p><strong>Acute Leukaemia</strong></p><ul><li>Pallor</li><li>Fever</li><li>Skin and mucosal haemorrhages</li><li>Gum hypertrophy (AML subtype 5)</li><li>Firm, rubbery, non-tender lymph nodes (lymphoid leukaemia)</li><li>Splenomegaly</li></ul><h3>Chronic Leukaemia</h3><ul><li>Splenomegaly</li><li>Weight loss</li><li>Pallor</li><li>Generalized lymph node enlargement in CLL</li></ul><h3>INVESTIGATIONS</h3><ul><li>FBC and blood film comment</li><li>Bone marrow aspirate</li><li>Uric acid levels</li><li>LDH</li><li>BUE and creatinine</li><li>Liver function tests</li><li>Septic screen (especially in acute leukaemia)</li><li>LP for CSF cytology (especially in acute lymphoid leukaemia)</li></ul><h3>TREATMENT</h3><h3>Treatment objectives</h3><ul><li>To aim for a cure in ALL in both children and adults</li><li>To achieve remission and prolong good quality life in AML</li><li>To aim for a complete haematological remission or cure in philadelphia positive CML</li><li>To control white cell counts, symptoms and prolong good quality of life in philadelphia negative CML</li><li>To provide supportive treatment (pain relief, transfusion support, treat infections,counselling)</li></ul><h3>Non-pharmacological treatment</h3><ul><li>Ensure good hydration</li><li>Ensure good nutrition and food hygiene</li><li>Ensure good oral and personal hygiene</li></ul><h3>Pharmacological treatment</h3><p><span ><strong>A. Treatment of the newly diagnosed patient</strong></span><strong> Supportive treatment</strong></p><ul><li>Pain relief (avoid NSAIDS)</li><li>Packed red cells transfusion and platelet transfusion when indicated</li><li>IV and oral fluids</li><li>Allopurinol to mitigate tumour lysis</li><li>Treatment of infections</li></ul><p><span >Specific treatment</span></p><ul><li>Available at specialized tertiary centres only</li></ul><h3>REFERRAL CRITERIA</h3><p><span >Refer all patients to the haematologist at a specialized tertiary centre for confirmation of diagnosis and start of management. Follow-up can continue at a regional centre by a physician under the distant guidance of a haematologist.</span></p>
</body>
</html>
